Difference between revisions of "Part:BBa K1159012:Design"
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K1159012 short</partinfo> | <partinfo>BBa_K1159012 short</partinfo> | ||
Line 5: | Line 4: | ||
<partinfo>BBa_K1159012 SequenceAndFeatures</partinfo> | <partinfo>BBa_K1159012 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | <br>'''Keywords:''' | ||
+ | <!--These keywords are necessary to find your part using a fulltext sarch.--> | ||
+ | <!--keyword_1, keyword_2, keyword_3, keyword_4, keyword_5--> | ||
+ | |||
+ | <br>'''Abbreviations:''' | ||
+ | *CaMV = Cauliflower Mosaic Virus | ||
+ | <!--*used_abbreviation_2 = full_name_of_used_abbreviations_2--> | ||
===Design Notes=== | ===Design Notes=== | ||
− | |||
+ | '''Related BioBrick:''' | ||
+ | <!--*Other versions:[https://parts.igem.org/wiki/index.php?title=Part:BBa_?????? BBa_??????: Name_of_part] --> | ||
+ | <!--*Related BioBricks:[https://parts.igem.org/wiki/index.php?title=Part:BBa_?????? BBa_??????: Name_of_part] | ||
+ | '''Cloning details:'''<br> | ||
+ | *Designed in RFC10 | ||
+ | *Template did not contain RFC restriction sites | ||
+ | <!--*Truncation upstream/downstream compared to template, ?explanation?--> | ||
+ | |||
+ | '''Quality control measures:'''<br> | ||
+ | <!--*Test digestion using ?enzyme1? & ?enzyme2?/Not yet performed--> | ||
+ | <!--*Sequencing using primer ?primer_name?/Not yet sequenced--> | ||
+ | <!--*Part was partly sequenced/Part was totally sequenced--> | ||
+ | |||
+ | '''Backbone:'''<br> | ||
+ | *Backbone name: pSB1C3 | ||
+ | *Resistance: Cp | ||
+ | <!--*Copynumber: low/medium/high--> | ||
+ | |||
+ | '''Protein coding:'''<br> | ||
+ | *no | ||
+ | |||
+ | '''Enzymatic activity:''' | ||
+ | *none | ||
+ | |||
+ | '''Cytotoxicity:'''<br> | ||
+ | *none | ||
+ | |||
+ | '''Safety notes:'''<br> | ||
+ | *Known and anticipated sefety issues: none | ||
+ | *Known and anticipated security issues: none | ||
+ | |||
+ | '''Intellectual property:''' | ||
+ | <!--Information on patent situation.--> | ||
+ | <!--Intellectual property claims made by the authors.--> | ||
+ | |||
+ | '''Corresponding part author/authors:''' | ||
+ | <!--https://igem.org/User_Information.cgi?user_id=????/email--> | ||
===Source=== | ===Source=== | ||
− | + | '''Source:'''<br> | |
+ | <!--*Commercial system: plasmid name, system name, company name--> | ||
+ | *Plasmid: pluc-Actin, provided by Prof. Dr. R. Reski, Freiburg University, Germany--> | ||
+ | <!--*Preexisting BioBrick ?Bba_number?--> | ||
+ | <!--*cDNA Clone: ?clone_name?, ?company_name?--> | ||
+ | <!--*Synthesized by ?company_name?.--> | ||
+ | |||
+ | <!--'''Forward Primer:'''<br><code>5'- ??? - 3'</code><br>--> | ||
+ | <!--'''Reverse Primer:'''<br><code>5'- ??? - 3'</code><br>--> | ||
+ | |||
+ | '''Organism:'''<br> | ||
+ | <!--*Genesequence derived from ''?organism_name?''--> | ||
+ | <!--*Codonoptimized for ''?organism_name?''--> | ||
+ | *Designed for the following Chassis: plant | ||
+ | <!--*Statement about functionality in other chassis.--> | ||
+ | |||
+ | <!--Thank you very much for using BBF RFC 82 to describe the present BioBrick. If you have any remarks or recommendations concerning this RFC we would highly appreciate to get your feedback on: []--> | ||
+ | |||
===References=== | ===References=== | ||
+ | <!-- Here you find templates to insert references to literature and different databases--> | ||
+ | |||
+ | '''Literature references:'''<br> | ||
+ | <!--*[http://www.ncbi.nlm.nih.gov/pubmed/?PMID? '''Pubmed:''' ?Author(s)?, ?year?: ?title?]--> | ||
+ | |||
+ | '''Database references:'''<br> | ||
+ | <!--*[http://www.ncbi.nlm.nih.gov/nuccore/?accessNr? '''GenBank''': ?title?]--> | ||
+ | <!--*[http://www.ebi.ac.uk/interpro/IEntry?ac=?accessNr? '''Interpro''': ?title?]--> | ||
+ | <!--*[http://www.uniprot.org/uniprot/?accessNr? '''Uniprot''': ?title?]--> | ||
+ | <!--*[http://pfam.sanger.ac.uk/family/?accessNr? '''Pfam:''' ?title?]--> | ||
+ | <!--*[http://www.rcsb.org/pdb/explore/explore.do?structureId=?accessNR? '''PDB:''' ?tile?]--> | ||
+ | <!--*[http://www.brenda-enzymes.info/php/result_flat.php4?ecno=?accessNr? '''Branda:''' ?title?]--> |
Latest revision as of 15:12, 17 May 2013
Secretory Catechol-2,3-dioxygenase (SERK-SigP_XylE) in RFC[25] N-Part
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Keywords:
Abbreviations:
- CaMV = Cauliflower Mosaic Virus
Design Notes
Related BioBrick:
Quality control measures:
Backbone:
- Backbone name: pSB1C3
- Resistance: Cp
Protein coding:
- no
Enzymatic activity:
- none
Cytotoxicity:
- none
Safety notes:
- Known and anticipated sefety issues: none
- Known and anticipated security issues: none
Intellectual property:
Corresponding part author/authors:
Source
Source:
- Plasmid: pluc-Actin, provided by Prof. Dr. R. Reski, Freiburg University, Germany-->
Organism:
- Designed for the following Chassis: plant
References
Literature references:
Database references: